Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Barttin CLCNK-type chloride channel accessory beta subunit pseudogene 1 (BSNDP1) is classified as a human pseudogene located on chromosome 20p11.1[6]. It shares sequence similarity with the functional gene BSND, which encodes the barttin protein, an essential accessory subunit for CLC-Ka and CLC-Kb chloride channels in the kidney and inner ear[1][2][3][5][7]. However, BSNDP1 itself does not produce a protein and does not have a documented biological or therapeutic role. All clinically relevant functions, disease associations, or drug interactions pertain to the BSND gene, not BSNDP1.\n\nIf information about a therapeutic target, transporter, or receptor is required, it is necessary to refer to the BSND gene and its product, barttin—not this pseudogene[1][2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Barttin CLCNK-type chloride channel accessory beta subunit pseudogene 1 (BSNDP1).